New! Sign up for our free email newsletter.
Science News
from research organizations

Early antiretroviral therapy linked with bone loss in patients with HIV

Date:
June 26, 2017
Source:
Wiley
Summary:
Current HIV treatment guidelines now recommend initiating antiretroviral treatment (ART) at the time of diagnosis. However, a new study has found that such early ART causes greater bone loss compared with deferring ART.
Share:
FULL STORY

Current HIV treatment guidelines now recommend initiating antiretroviral treatment (ART) at the time of diagnosis. However, a new study has found that such early ART causes greater bone loss compared with deferring ART.

The study followed 399 participants (195 immediate ART and 204 deferred ART) for an average of 2.2 years. Although the study revealed a negative effect on bone density of immediate ART, the overall benefits of ART for preventing HIV transmission and adverse health outcomes prevail. It will be important to understand the long-term consequences of reductions in bone mineral density associated with ART and whether these reductions continue or stabilise with longer therapy.

"What we found was that starting treatment is also associated with accelerated bone loss of about 2-4%, and the rate of decline then appears to slow after the first 2 years of treatment, compared with HIV positive people who deferred treatment," said Prof. Jennifer Hoy, lead author of the Journal of Bone and Mineral Research study. "We have no cure for HIV, so antiretroviral treatment is for life. An increased rate of bone loss may become important years later, in the setting of increased risk of fragility fracture."


Story Source:

Materials provided by Wiley. Note: Content may be edited for style and length.


Journal Reference:

  1. Jennifer F Hoy, Birgit Grund, Mollie Roediger, Ann V Schwartz, John Shepherd, Anchalee Avihingsanon, Sharlaa Badal-Faesen, Stephane de Wit, Simone Jacoby, Alberto La Rosa, Sanjay Pujari, Mauro Schechter, David White, Nicole Wyman Engen, Kristine Ensrud, Peer D Aagaard, Andrew Carr. Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial. Journal of Bone and Mineral Research, 2017; DOI: 10.1002/jbmr.3183

Cite This Page:

Wiley. "Early antiretroviral therapy linked with bone loss in patients with HIV." ScienceDaily. ScienceDaily, 26 June 2017. <www.sciencedaily.com/releases/2017/06/170626142255.htm>.
Wiley. (2017, June 26). Early antiretroviral therapy linked with bone loss in patients with HIV. ScienceDaily. Retrieved November 20, 2024 from www.sciencedaily.com/releases/2017/06/170626142255.htm
Wiley. "Early antiretroviral therapy linked with bone loss in patients with HIV." ScienceDaily. www.sciencedaily.com/releases/2017/06/170626142255.htm (accessed November 20, 2024).

Explore More

from ScienceDaily

RELATED STORIES